Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil

Kidney International

Volumn 71, Issue 1, 2007, Pages 24-30

  Sun, Q ^a   Liu, Z H ^a   Cheng, Z ^a   Chen, J ^a   Ji, S ^a   Zeng, C ^a   Li, L S ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Acute humoral rejection; Kidney transplantation; Mycophenolate mofetil; Tacrolimus

Indexed keywords

CD4 ANTIGEN; CEFOPERAZONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ARTICLE; CLINICAL ARTICLE; COMPLEMENT DEPENDENT CYTOTOXICITY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE COURSE; DRUG EFFICACY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; KIDNEY ALLOGRAFT REJECTION; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; THERAPY EFFECT; TREATMENT OUTCOME; URINARY TRACT INFECTION;

ACUTE DISEASE; ADULT; FEMALE; GRAFT REJECTION; HUMANS; IMMUNITY, CELLULAR; IMMUNOSUPPRESSIVE AGENTS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PROSPECTIVE STUDIES; TACROLIMUS;

EID: 33845703244     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001870     Document Type: Article

References (33)

1. Mauiyyedi S, Colvin RB. Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment. Curr Opin Nephrol Hypertens 2002; 11: 609-618.
2. Lederer SR, Friedrich N, Banas B et al. Effects of mycophenolate mofetil on donor-specific antibody formation in renal transplantation. Clin Transplant 2005; 19: 168-174.
3. Feucht HE, Opelz G. The humoral immune response towards HLA class II determinants in renal transplantation. Kidney Int 1996; 50: 1464-1475.
4. Baldwin WM, Halloran PF. Clinical syndromes associated with antibody in allografts. In: Racusen LC, Solez K, Burdick JF (eds). Kidney Transplant Rejection. Marcel Dejjer Inc: New York, 1998, pp 127-147.
5. McKenna RM, Takemoto SK, Terasaki PI. Anti-HLA antibodies after solid organ transplantation. Transplantation 2000; 69: 319-326.
6. Bohmig GA, Regele H, Exner M et al. C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption. J Am Soc Nephrol 2001; 12: 2482-2489.
7. Crespo M, Pascual M, Tolkoff-Rubin N et al. Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics. Transplantation 2001; 71: 652-658.
8. Montgomery RA, Zachary AA, Racusen LC et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 2000; 70: 887-895.
9. Rocha PN, Butterly DW, Greenberg A et al. Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection. Transplantation 2003; 75: 1490-1495.
10. Aringer M, Smolen JS, Graninger WB. Severe infections in plasmapheresis-treated systemic lupus erythematosus. Arthritis Rheum 1998; 41: 414-420.
11. Takemoto SK, Zeevi A, Feng S et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 2004; 4: 1033-1041.
12. Sun Q, Liu ZH, Yin G et al. Tacrolimus combined with mycophenolate mofetil can effectively reverse C4d-positive steroid-resistant acute rejection in Chinese renal allograft recipients. Nephrol Dial Transplant 2006; 21: 510-517.
13. Nickeleit V, Zeiler M, Gudat F et al. Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol 2003; 13: 242-251.
14. Koo DD, Roberts IS, Quiroga I et al. C4d deposition in early renal allograft protocol biopsies. Transplantation 2004; 78: 398-403.
15. Sun Q, Liu ZH, Ji S et al. Late and early C4d-positive acute rejection: different clinico-histopathological entities in renal transplantation. Kidney Int 2006; 70: 377-383.
16. Bock HA. Steroid-resistant kidney transplant rejection: diagnosis and treatment. J Am Soc Nephrol 2001; 12: S48-S52.
17. Pascual M, Saidman S, Tolkoff-Rubin N et al. Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation. Transplantation 1998; 66: 1460-1464.
18. Racusen LC, Halloran PF, Solez K. Banff 2003 meeting report: new diagnostic insights and standards. Am J Transplant 2004; 4: 1562-1566.
19. Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria -an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708-714.
20. Montgomery RA, Hardy MA, Jordan SC et al. Antibody Working Group on the diagnosis, reporting, and risk assessment for antibody-mediated rejection and desensitization protocols: consensus opinion from the antibody working group on the diagnosis, reporting, and risk assessment for antibody-mediated rejection and desensitization protocols. Transplantation 2004; 78: 181-185.
21. Suciu-Foca N, Reed E, Rohowsky C et al. Anti-idiotypic antibodies to anti-HLA receptors induced by pregnancy. Proc Natl Acad Sci USA 1983; 80: 830-834.
22. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333: 333-336.
23. Allen NH, Dyer P, Geoghegan T et al. Plasma exchange in acute renal allograft rejection. A controlled trial. Transplantation 1983; 35: 425-428.
24. Kimball JA, Pescovitz MD, Book BK, Norman DJ. Reduced human IgG anti-ATGAM antibody formation in renal transplant recipients receiving mycophenolate mofetil. Transplantation 1995; 60: 1379-1383.
25. Sun Q, Liu Z, Yin G et al. Detectable circulating antiendothelial cell antibodies in renal allograft recipients with C4d-positive acute rejection: a report of three cases. Transplantation 2005; 79: 1759-1762.
26. Lehrich RW, Rocha PN, Reinsmoen N et al. Intravenous immunoglobulin and plasmapheresis in acute humoral rejection: experience in renal allograft transplantation. Hum Immunol 2005; 66: 350-358.
27. Karpinski M, Rush D, Jeffery J et al. Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch. J Am Soc Nephrol 2001; 12: 2807-2814.
28. Eibl MM, Wedgwood RJ. Intravenous immunoglobulin: a review. Immunodefic Rev 1989; 1(Suppl): 1-42.
29. Nickeleit V, Mihatsch M. Kidney transplants, antibodies and rejection: is C4d a magic marker? Nephrol Dial Transplant 2003; 18: 2232-2239.
30. Thurman JM, Lucia MS, Ljubanovic D, Holers VM. Acute tubular necrosis is characterized by activation of the alternative pathway of complement. Kidney Int 2005; 67: 524-530.
31. Haas M, Ratner LE, Montgomery RA. C4d staining of perioperative renal transplant biopsies. Transplantation 2002; 74: 711-717.
32. Wu JY, Chen JH, Wang YM et al. Improved clinical outcomes in Chinese renal allograft recipients receiving lower dose immunosuppressants. Transplantation 2004; 78: 713-718.
33. Pei R, Wang G, Tarsitani C et al. Simultaneous HLA class I and class II antibodies screening with flow cytometry. Hum Immunol 1998; 59: 313-322.